These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 932503)
1. Paradoxical effects of immunopotentiators on tumors and tumor viruses. Morahan PS; Schuller GB; Snodgrass MJ; Kaplan AM J Infect Dis; 1976 Jun; 133 Suppl():A249-55. PubMed ID: 932503 [TBL] [Abstract][Full Text] [Related]
2. Macrophage mediated tumor cell cytotoxicity. Kaplan AM; Morahan PS Ann N Y Acad Sci; 1976; 276():134-45. PubMed ID: 1071961 [TBL] [Abstract][Full Text] [Related]
3. Positive correlation between the levels of natural killer cells and the in vivo resistance to syngeneic tumor transplants as influenced by various routes of administration of Corynebacterium parvum bacteria. Ojo E Cell Immunol; 1979 Jun; 45(1):182-7. PubMed ID: 455483 [No Abstract] [Full Text] [Related]
4. Inhibition and enhancement of Friend leukemia virus by pyran copolymer. Schuller GB; Morahan PS; Snodgrass M Cancer Res; 1975 Aug; 35(8):1915-20. PubMed ID: 1149015 [TBL] [Abstract][Full Text] [Related]
5. Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours. Smith SE; Scott MT Br J Cancer; 1972 Oct; 26(5):361-7. PubMed ID: 4343677 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of erythroid target cells for Friend murine leukemia virus by intravenous pyran treatment. Schuller GB; Morahan PS J Natl Cancer Inst; 1979 May; 62(5):1257-60. PubMed ID: 286101 [TBL] [Abstract][Full Text] [Related]
7. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems. Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517 [TBL] [Abstract][Full Text] [Related]
8. [Effect of immunostimulation by Corynebacterium parvum on evolution and metastatic dissemination of Lewis's tumor in mouse C57BL/6 mice]. Pot-Deprun J; Chouroulinkov I C R Acad Hebd Seances Acad Sci D; 1975 Feb; 280(5):685-8. PubMed ID: 809167 [TBL] [Abstract][Full Text] [Related]
9. Tumor-specific T-lymphocyte cytotoxicity enhanced by low dose of C. parvum. Lau BH; Wang-Cheng RM; Tosk J J Leukoc Biol; 1987 May; 41(5):407-11. PubMed ID: 3494802 [TBL] [Abstract][Full Text] [Related]
10. Active, specific immunotherapy of murine leukemia. II. Adjuvant effect of Corynebacterium parvum. Bartlett GL; Kreider JW Int J Cancer; 1979 Nov; 24(5):636-43. PubMed ID: 528079 [TBL] [Abstract][Full Text] [Related]
11. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models. Bartlett GL; Kreider JW; Purnell DM Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633 [TBL] [Abstract][Full Text] [Related]
12. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice. Kiya K; Toge T; Harada K; Uozumi T; Hattori T Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201 [TBL] [Abstract][Full Text] [Related]
13. Influence of C. parvum on the effectiveness of passive serotherapy in the control of the EL4 lymphoma in C57BL/6 mice. O'Neill GJ; Stebbing N Br J Cancer; 1980 Feb; 41(2):243-9. PubMed ID: 7370164 [TBL] [Abstract][Full Text] [Related]
14. Pyran copolymer as an effective adjuvant to chemotherapy against a murine leukemia and solid tumor. Mohr SJ; Chirigos MA; Fuhrman FS; Pryor JW Cancer Res; 1975 Dec; 35(12):3750-4. PubMed ID: 1192431 [TBL] [Abstract][Full Text] [Related]
15. Lack of immunological and anti-tumour effects of orally administered Corynebacterium papvum in mice. Sadler TE; Castro JE Br J Cancer; 1975 Mar; 31(3):359-63. PubMed ID: 1156520 [No Abstract] [Full Text] [Related]
16. Antimetastatic effect of cell-wall skeleton of Propionibacterium acnes C7 on Lewis lung carcinoma in C57BL/6J mice. Tanio Y; Yamamura Y; Saiki I; Okumura H; Kamisango K; Okuyama H; Azuma I Gan; 1981 Jun; 72(3):403-10. PubMed ID: 7319198 [TBL] [Abstract][Full Text] [Related]
17. Combined radiotherapy and Corynebacterium parvum treatment of a murine fibrosarcoma. Collins AL; Song CW Radiology; 1977 Oct; 125(1):235-41. PubMed ID: 897175 [TBL] [Abstract][Full Text] [Related]
18. [Inhibitory action of Corynebacterium parvum on the development of malignant syngenic tumors, and its mechanism]. Halpern B; Fray A; Crepin Y; Platica O; Sparros L; Lorinet AM; Rabourdin A C R Acad Hebd Seances Acad Sci D; 1973 Mar; 276(12):1911-5. PubMed ID: 4201539 [No Abstract] [Full Text] [Related]
19. Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice. Woodruff MF; Warner NL J Natl Cancer Inst; 1977 Jan; 58(1):111-6. PubMed ID: 299893 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system. Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]